Arcellx, Inc. (ACLX)

68.41 -0.46 (-0.67%) USD  |  NASDAQ  |  Jan 22, 14:51
More

Arcellx EPS Diluted from Accounting Change (Quarterly)

EPS Diluted from Accounting Change (Quarterly) Chart

View EPS Diluted from Accounting Change (Quarterly) for ACLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Accounting Change (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years

View EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Accounting Change (Quarterly) Benchmarks

View EPS Diluted from Accounting Change (Quarterly) Benchmarks
Start Trial
Gilead Sciences, Inc. --
Johnson & Johnson --
Amicus Therapeutics, Inc. --
Relmada Therapeutics, Inc. --
Invivyd, Inc. --